RANTES expression is a predictor of survival in stage I lung adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Cancer Research

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 12473593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1

  2002cited by this paper
• Gene-expression profiles predict survival of patients with lung adenocarcinoma

  2002cited by this paper
• IFN-γ-Inducible Protein-10 Is Essential for the Generation of a Protective Tumor-Specific CD8 T Cell Response Induced by Single-Chain IL-12 Gene Therapy1

  2001cited by this paper
• Role of Chemokines and Formyl Peptides in Pneumococcal Pneumonia-Induced Monocyte/Macrophage Recruitment2

  2001cited by this paper
• Diversity of gene expression in adenocarcinoma of the lung

  2001cited by this paper
• Epithelial cancer cell migration: a role for chemokine receptors?

  2001cited by this paper
• IFN-g-Inducible Protein-10 Is Essential for the Generation of a Protective Tumor-Specific CD8 T Cell Response Induced by Single-Chain IL-12 Gene Therapy

  2001cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.

  2001cited by this paper
• Cyclophosphamide stimulates lung fibroblasts to release neutrophil and monocyte chemoattractants.

  2001cited by this paper
• High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis.

  2001cited by this paper
• RANTES: a versatile and controversial chemokine.

  2001cited by this paper
• Chemokines, Chemokine Receptors and Allergy

  2001cited by this paper
• Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

  2001cited by this paper
• Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.

  2001cited by this paper
• Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer.

  2001cited by this paper
• Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

  2001cited by this paper
• Lymphocyte traffic control by chemokines

  2001cited by this paper
• Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and RANTES expression by human airway epithelial cells.

  2001cited by this paper
• Chemokines and disease

  2001cited by this paper
• Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen

  2001cited by this paper
• A fresh look at tumor immunosurveillance and immunotherapy

  2001cited by this paper
• Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival

  2000cited by this paper
• Immune cell infiltrates and prognosis in primary carcinoma of the lung.

  2000cited by this paper
• Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma

  2000cited by this paper
• Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines

  2000influential reference
• Role of CC Chemokines (Macrophage Inflammatory Protein-1β, Monocyte Chemoattractant Protein-1, RANTES) in Acute Lung Injury in Rats1

  2000cited by this paper
• Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma

  1999cited by this paper
• Expression of RANTES by normal airway epithelial cells after influenza virus A infection.

  1998cited by this paper
• Quantitative analysis of Th1, Th2 and TGF‐β1 cytokine expression in tumor, TIL and PBL of non‐small cell lung cancer patients

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

  1997cited by this paper
• Immunobiology: The Immune System in Health and Disease

  1996cited by this paper
• Is cancer dangerous to the immune system?

  1996cited by this paper
• Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

  1996cited by this paper
• RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity In Vivo: Role of Immune Cell Subpopulations

  1996cited by this paper
• Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.

  1996cited by this paper
• Interferon-y-inducib le Prote in 10 ( IP-10 ) Is an Angiostat ic Factor That Inhibits

  1996cited by this paper
• Human non-small cell lung cancer cells express a type 2 cytokine pattern.

  1995cited by this paper
• Survival predictors in advanced non-small cell lung cancer.

  1995cited by this paper
• IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

  1993cited by this paper
• Lung cancer staging classification.

  1993cited by this paper
• Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung.

  1992cited by this paper
• K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.

  1990cited by this paper
• Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

  1990cited by this paper
• Regulation of the macrophage content of neoplasms by chemoattractants.

  1983cited by this paper

• miR-9-5p regulates CCL5 mediated inflammatory responses in macrophages exposed to PM10.

  2025cites this paper
• Inflammatory cytokine profile in non-small cell lung Cancer (NSCLC) patients during early enhanced recovery after surgery (ERAS) period and its relation to hospital length of stay.

  2025cites this paper
• Hepatic Growth Factor as a Potential Biomarker for Lung Adenocarcinoma: A Multimodal Study

  2025cites this paper
• CCR5 expression defines the functional heterogeneity of tumor-infiltrating CD8+ T cells and predicts enhanced antitumor immunity and favorable prognosis in non-small cell lung cancer.

  2025cites this paper
• Club cell‐specific telomere protection protein 1 (TPP1) protects against tobacco smoke‐induced lung inflammation, xenobiotic metabolic dysregulation, and injurious responses

  2024cites this paper
• Macrophage CD5L is a target for cancer immunotherapy

  2023cites this paper
• Derivation of CD8+ T cell infiltration potentiators in non-small-cell lung cancer through tumor microenvironment analysis

  2023cites this paper
• A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer

  2022cites this paper
• Evaluation of the Effect of Radiotherapy on CCL5/miR-214 -3p/MALAT1 Genes Expression in Blood Samples of Breast Cancer Patients

  2022cites this paper
• Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.

  2021cites this paper
• Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC

  2021cites this paper
• CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development

  2021cites this paper
• Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma

  2020cites this paper
• 11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma

  2020cites this paper
• Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma

  2020cites this paper
• Arnt differentially regulate NF-κ B signaling and chemokine responses in human bronchial epithelial cells

  2019cites this paper
• The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer

  2019cites this paper
• A Machine‐Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma

  2019cites this paper
• Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target.

  2019cites this paper
• The emerging role of epigenetic therapeutics in immuno-oncology

  2019cites this paper
• Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments

  2018cites this paper
• What a dog transmissible tumor can teach us about cancer regression

  2018cites this paper
• High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.

  2017cites this paper
• Human MSCs promotes colorectal cancer epithelial–mesenchymal transition and progression via CCL5/β-catenin/Slug pathway

  2017cites this paper
• Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.

  2017cites this paper
• Leukocyte trafficking in tumor microenvironment.

  2017cites this paper
• -Nitrosourea-Induced T N -Methyl- NResistance to Pathogenesis of Role of IFN Regulatory Factor-1 and IL-12 in

  2017cites this paper
• Molecular Basis of Lung Carcinogenesis

  2017cites this paper
• The molecular and mechanical mechanisms of the age-associated increase in the severity of experimental ventilator induced lung injury

  2016cites this paper
• Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors

  2016cites this paper
• Contribution of complement anaphylatoxin receptors to melanoma growth: potential therapeutic targets

  2016cites this paper
• The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses

  2016cites this paper
• Chemokines accentuating protumoral activities in oral cancer microenvironment possess an imperious stratagem for therapeutic resolutions.

  2016cites this paper
• Toward the Identification of Genetic Determinants of Responsiveness to Cancer Immunotherapy

  2015cites this paper
• Loss of RUNX3 expression promotes cancer‐associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non‐small cell lung cancer

  2015cites this paper
• The Importance of the Insulin-like Growth Factor Signaling Pathway in Lung Cancer and the Potential of its Components as Therapeutic Targets

  2015cites this paper
• Chemokine (C‐C Motif) Ligand 5 is Involved in Tumor‐Associated Dendritic Cell‐Mediated Colon Cancer Progression Through Non‐Coding RNA MALAT‐1

  2015cites this paper
• Mechanisms of human lymphotoxin beta receptor activation on upregulation of CCL5/RANTES production.

  2015cites this paper
• Targeting roles of inflammatory microenvironment in lung cancer and metastasis

  2015cites this paper
• Optimisation d'un vaccin thérapeutique dans les tumeurs des voies aérodigestives supérieures associées aux papillomavirus : rôle de l'induction d'une immunité muqueuse et de la combinaison à la radiothérapie

  2015cites this paper
• Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy

  2015cites this paper
• Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation

  2015influential citation
• The role of inflammation in lung cancer.

  2014cites this paper
• The Immune Microenvironment: A Major Player in Human Cancers

  2014cites this paper
• AhR and Arnt differentially regulate NF-κB signaling and chemokine responses in human bronchial epithelial cells

  2014cites this paper
• Pharmacological intervention at CCR1 and CCR5 as an approach for cancer: help or hindrance.

  2014cites this paper
• Microarray Analysis Identifies Pathways In Progression of Early Stage Lung Adenocarcinoma: The Importance of Focal Adhesion and ECM-Receptor Interactions

  2014cites this paper
• Chemokine Gene-Modified Dendritic Cells for Cancer Therapy

  2014cites this paper
• Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer

  2014cites this paper
• The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

  2013cites this paper
• Association Study of Chemokine (C–C motif) Ligand 5 Gene Polymorphism and Papillary Thyroid Cancer

  2013cites this paper
• Peripheral Tissue Homing Receptor Control of Naïve, Effector, and Memory CD8 T Cell Localization in Lymphoid and Non-Lymphoid Tissues

  2013cites this paper
• CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

  2013influential citation
• SYNERGY BETWEEN JAK INHIBITOR RUXOLITINIB AND TYROSINE KINASE INHIBITORS TO OVERCOME DRUG RESISTANCE RELATED TO BONE MARROW STROMA MICROENVIRONMENT IN CHRONIC MYELOID LEUKEMIA

  2013cites this paper
• Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

  2013cites this paper
• Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs

  2013cites this paper
• Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.

  2013cites this paper
• in Lung Adenocarcinoma CD4+CXCR4highCD69+ T Cells Accumulate

  2013cites this paper
• Cell Death and Survival STAT 3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells

  2013cites this paper
• CCL5 as a potential immunotherapeutic target in triple-negative breast cancer

  2013cites this paper
• Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response.

  2012influential citation
• Biological effects of alpha particle radiation exposure on human monocytic cells.

  2012cites this paper
• Molecular Predictors of Prognosis in Lung Cancer

  2012cites this paper
• Protein Signature of Lung Cancer Tissues

  2012cites this paper
• Functional Screen for Secreted Proteins by Monoclonal Antibody Library and Identification of Mac-2 Binding Protein (Mac-2BP) as a Potential Therapeutic Target and Biomarker for Lung Cancer*

  2012cites this paper
• Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.

  2012cites this paper
• STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells

  2012cites this paper
• Regulation of CC Ligand 5/RANTES by Acid Sphingomyelinase and Acid Ceramidase*

  2011cites this paper
• Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer

  2010influential citation
• The Immune Response to Non-Small Cell Lung Cancer

  2010cites this paper
• Gene therapy to improve migration of T cells to the tumor site.

  2010cites this paper
• Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study

  2010cites this paper
• Differential effects of nitro-PAHs and amino-PAHs on cytokine and chemokine responses in human bronchial epithelial BEAS-2B cells.

  2010cites this paper
• Establishment of a Multi-Analyte Serum Biomarker Panel to Identify Lymph Node Metastases in Non-small Cell Lung Cancer

  2009cites this paper
• RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women

  2008cites this paper
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

  2008cites this paper
• Lung adenocarcinoma invasion in TGFβRII-deficient cells is mediated by CCL5/RANTES

  2008cites this paper
• Tumor-derived CCL5 does not contribute to breast cancer progression

  2008cites this paper
• Tumour-immune cell interactions modulated by chemokines

  2008cites this paper
• Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.

  2007cites this paper
• Role of chemokines in tumor growth.

  2007cites this paper
• regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.

  2007cites this paper
• Inflammatory cell infiltration of tumors: Jekyll or Hyde

  2007cites this paper
• International comparisons of survival from lung cancer: pitfalls and warnings

  2007cites this paper
• [Chemokines: a sophisticated cell-guidance network].

  2007cites this paper
• Modulation of RANTES expression by HCV core protein in liver derived cell lines

  2007cites this paper
• Elucidation of veA-dependent genes associated with aflatoxin and sclerotial production in Aspergillus flavus by functional genomics

  2007cites this paper
• Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

  2007cites this paper
• Les chimiokines : un réseau sophistiqué de guidage cellulaire

  2007cites this paper
• An array of possibilities in cancer research using cytokine antibody arrays

  2007cites this paper
• Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.

  2007cites this paper
• CXCR4CD69 T Cells Accumulate in Lung Adenocarcinoma

  2006cites this paper
• CD4+CXCR4highCD69+ T Cells Accumulate in Lung Adenocarcinoma

  2006cites this paper
• Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment

  2006cites this paper
• Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.

  2006cites this paper
• Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

  2006cites this paper
• Human lung project: evaluating variance of gene expression in the human lung.

  2006cites this paper
• The chemokine network: a target in cancer biology?

  2006cites this paper
• Expression of CCL5 (RANTES) and CCR5 in prostate cancer

  2006cites this paper
• STRUCTURE AND SPARSITY IN HIGH-DIMENSIONAL MULTIVARIATE ANALYSIS

  2006cites this paper